Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Elanco Animal Health Incorporated stock logo
ELAN
Elanco Animal Health
$23.55
+1.6%
$23.01
$13.39
$27.72
$11.76B1.695.45 million shs6,532 shs
Wells Fargo & Company stock logo
WFC
Wells Fargo & Company
$84.27
+0.2%
$79.63
$72.78
$97.76
$257.64B0.9316.97 million shs3,708 shs
Analysts Agree—These Gold Picks Outshine the Rest Cover

Unlock the timeless value of gold with our exclusive 2026 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Elanco Animal Health Incorporated stock logo
ELAN
Elanco Animal Health
-2.93%-4.21%+6.62%-8.79%+73.73%
Wells Fargo & Company stock logo
WFC
Wells Fargo & Company
+0.40%-0.80%+10.15%+5.04%+9.43%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Elanco Animal Health Incorporated stock logo
ELAN
Elanco Animal Health
$23.55
+1.6%
$23.01
$13.39
$27.72
$11.76B1.695.45 million shs6,532 shs
Wells Fargo & Company stock logo
WFC
Wells Fargo & Company
$84.27
+0.2%
$79.63
$72.78
$97.76
$257.64B0.9316.97 million shs3,708 shs
Analysts Agree—These Gold Picks Outshine the Rest Cover

Unlock the timeless value of gold with our exclusive 2026 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Elanco Animal Health Incorporated stock logo
ELAN
Elanco Animal Health
-2.93%-4.21%+6.62%-8.79%+73.73%
Wells Fargo & Company stock logo
WFC
Wells Fargo & Company
+0.40%-0.80%+10.15%+5.04%+9.43%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Elanco Animal Health Incorporated stock logo
ELAN
Elanco Animal Health
2.79
Moderate Buy$28.5521.23% Upside
Wells Fargo & Company stock logo
WFC
Wells Fargo & Company
2.69
Moderate Buy$98.2416.57% Upside

Current Analyst Ratings Breakdown

Latest ELAN and WFC Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
6/18/2026
Elanco Animal Health Incorporated stock logo
ELAN
Elanco Animal Health
Boost Price TargetBuy$31.00 ➝ $32.00
5/11/2026
Elanco Animal Health Incorporated stock logo
ELAN
Elanco Animal Health
DowngradeSell (D+)Sell (D)
5/7/2026
Elanco Animal Health Incorporated stock logo
ELAN
Elanco Animal Health
Boost Price TargetBuy$30.00 ➝ $31.00
5/7/2026
Elanco Animal Health Incorporated stock logo
ELAN
Elanco Animal Health
Boost Price TargetOverweight$28.00 ➝ $30.00
5/7/2026
Wells Fargo & Company stock logo
WFC
Wells Fargo & Company
UpgradeModerate BuyStrong-Buy
4/30/2026
Wells Fargo & Company stock logo
WFC
Wells Fargo & Company
Lower Price TargetNeutral$91.00 ➝ $86.50
4/27/2026
Elanco Animal Health Incorporated stock logo
ELAN
Elanco Animal Health
UpgradeSell (D)Sell (D+)
4/20/2026
Wells Fargo & Company stock logo
WFC
Wells Fargo & Company
Reiterated RatingBuy (B)
4/16/2026
Wells Fargo & Company stock logo
WFC
Wells Fargo & Company
DowngradeHold
4/15/2026
Wells Fargo & Company stock logo
WFC
Wells Fargo & Company
Reiterated RatingOverweight$100.00 ➝ $94.00
4/15/2026
Wells Fargo & Company stock logo
WFC
Wells Fargo & Company
Lower Price TargetOverweight$113.00 ➝ $108.00
(Data available from 6/24/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Elanco Animal Health Incorporated stock logo
ELAN
Elanco Animal Health
$4.72B2.49$2.29 per share10.30$13.18 per share1.79
Wells Fargo & Company stock logo
WFC
Wells Fargo & Company
$85.00B3.03$9.32 per share9.04$53.02 per share1.59
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Elanco Animal Health Incorporated stock logo
ELAN
Elanco Animal Health
-$232M-$0.50N/A19.301.57-4.95%7.42%3.66%8/6/2026 (Estimated)
Wells Fargo & Company stock logo
WFC
Wells Fargo & Company
$21.34B$6.4812.9910.830.9817.26%13.27%1.05%7/14/2026 (Estimated)

Latest ELAN and WFC Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
7/14/2026Q2 2026
Wells Fargo & Company stock logo
WFC
Wells Fargo & Company
$1.74N/AN/AN/A$21.83 billionN/A
5/6/2026Q1 2026
Elanco Animal Health Incorporated stock logo
ELAN
Elanco Animal Health
$0.34$0.40+$0.06$0.11$1.28 billion$1.37 billion
4/14/2026Q1 2026
Wells Fargo & Company stock logo
WFC
Wells Fargo & Company
$1.58$1.60+$0.02$1.60$21.85 billion$11.62 billion
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Elanco Animal Health Incorporated stock logo
ELAN
Elanco Animal Health
N/AN/AN/AN/AN/A
Wells Fargo & Company stock logo
WFC
Wells Fargo & Company
$1.802.14%+6.86%27.78%4 Years

Latest ELAN and WFC Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
4/28/2026
Wells Fargo & Company stock logo
WFC
Wells Fargo & Company
quarterly$0.452.38%5/8/20265/8/20266/1/2026
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Elanco Animal Health Incorporated stock logo
ELAN
Elanco Animal Health
0.60
2.16
1.12
Wells Fargo & Company stock logo
WFC
Wells Fargo & Company
1.12
0.90
0.90

Institutional Ownership

CompanyInstitutional Ownership
Elanco Animal Health Incorporated stock logo
ELAN
Elanco Animal Health
97.48%
Wells Fargo & Company stock logo
WFC
Wells Fargo & Company
75.90%

Insider Ownership

CompanyInsider Ownership
Elanco Animal Health Incorporated stock logo
ELAN
Elanco Animal Health
1.14%
Wells Fargo & Company stock logo
WFC
Wells Fargo & Company
0.14%
CompanyEmployeesShares OutstandingFree FloatOptionable
Elanco Animal Health Incorporated stock logo
ELAN
Elanco Animal Health
9,400499.45 million493.76 millionOptionable
Wells Fargo & Company stock logo
WFC
Wells Fargo & Company
205,0003.06 billion3.06 billionOptionable

Recent News About These Companies

Wells Fargo Remains a Buy on Constellation Energy (CEG)
Wells Fargo revamps S&P 500 target for the rest of 2026
12 Ultra-High Dividend Stocks to Buy for Income Investors
10 Best AI Memory Stocks to Buy in 2026
10 Stocks with Potential to Explode in 2026

New MarketBeat Followers Over Time

Media Sentiment Over Time

Elanco Animal Health stock logo

Elanco Animal Health NYSE:ELAN

$23.55 +0.37 (+1.58%)
As of 09:32 AM Eastern
This is a fair market value price provided by Massive. Learn more.

Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet health therapeutics for pain, osteoarthritis, ear infections, cardiovascular, and dermatology indications in canines and felines under the Galliprant and Claro brands; vaccines, antibiotics, parasiticides, and other products for use in poultry and aquaculture production, as well as nutritional health products, including enzymes, probiotics, and prebiotics; and a range of vaccines, antibiotics, implants, parasiticides, and other products used in ruminant and swine production under the Rumensin and Baytril brands. The company sells its products to third-party distributors; veterinarians; and farm animal producers, including beef and dairy farmers, as well as pork, poultry, and aquaculture operations. Elanco Animal Health Incorporated was founded in 1954 and is headquartered in Greenfield, Indiana.

Wells Fargo & Company stock logo

Wells Fargo & Company NYSE:WFC

$84.27 +0.14 (+0.17%)
As of 09:32 AM Eastern
This is a fair market value price provided by Massive. Learn more.

Wells Fargo & Co. is a diversified and community-based financial services company, which engages in the provision of banking, insurance, investments, mortgage, and consumer and commercial finance products and services. It operates through the following segments: Consumer Banking and Lending, Commercial Banking, Corporate and Investment Banking, and Wealth and Investment Management. The Consumer Banking and Lending segment offers consumer and small business banking, home lending, credit cards, auto, and personal lending. The Commercial Banking segment provides banking and credit products across industry sectors and municipalities, secured lending and lease products, and treasury management. The Corporate and Investment Banking segment is composed of corporate banking, investment banking, treasury management, commercial real estate lending and servicing, and equity and fixed income solutions, as well as sales, trading, and research capabilities. The Wealth and Investment Management segment refers to personalized wealth management, brokerage, financial planning, lending, private banking, trust, and fiduciary products and services. The company was founded by Henry Wells and William G. Fargo on March 18, 1852 and is headquartered in San Francisco, CA.